Translating groundbreaking science and precision delivery into life-changing medicines for people living with devastating neurodegenerative diseases.
London, Greater London
Joined July 2021
- Tweets416
- Following116
- Followers347
- Likes26
AviadoBio retweeted
Finding answers to an FTD diagnosis is often a long and difficult road. In our upcoming webinar, The Lived Experience with FTD: The Road to an Diagnosis, you'll hear three powerful stories that shed light on this journey.
📅 Thursday, September 25 at 12 p.m. ET
💻 Register here: bit.ly/3JLiqUL
Sponsored by @AviadoBio
ALT Promotional image for an AFTD HelpLine webinar titled 'The Lived Experience with FTD: The Road to an FTD Diagnosis' scheduled for September 25, 2025, featuring two individuals having a conversation in a modern office setting. The event is sponsored by AviadoBio.
AviadoBio retweeted
CONGRESS HISTORY: Rep. Jennifer Wexton (D-VA) uses AI tool to mirror her own voice in farewell speech on House floor.
@RepWexton has neurological disorder that affects her ability to speak ... artificial intelligence allows her to speak using her old voice
AviadoBio retweeted
We would like to congratulate three LifeArc Ventures portfolio companies, @AviadoBio, @Cumulus Neuroscience and @Maxion Therapeutics, who have been chosen for @PWC’s UK’s Life Sciences Future 50 report highlighting scientific excellence in the UK.
pwc.co.uk/industries/pharmac…
AviadoBio retweeted
🌎 Day four of World FTD Awareness Week is here, marking the midpoint of this global movement to #endFTD. Throughout the week, we're sharing insightful interviews on various facets of FTD and dementia, while also highlighting actions you can take to drive us towards a future free of FTD.
🙌 Today's theme revolves around volunteering, offering you avenues to make a difference:
1️⃣ Volunteer with AFTD or a dementia-focused organization in your country. If there's none accessible to you, consider sharing your personal FTD story on social media. Your voice is a potent tool for awareness. Remember to use hashtags #EndFTD, #ICareAboutFTD, or #WeCareAboutFTD.
2️⃣ Share your actions on social media. Find messaging and graphics at this link: bit.ly/3LFj0lb
AviadoBio retweeted
BioBoss podcast wyantsimboli.com/bioboss/lis… featuring Lisa Deschamps, #CEO AviadoBio. Hear Lisa speak with BioBoss host and Wyant Simboli principal John Simboli about #leadership in #biopharma. #BioBoss,#leadership,#innovation,#entrepreneurship,#biopharma,#biotech,#FTD,#ALS
AviadoBio retweeted
Farah Speer (@fspeer) presents on engaging patients and caregivers directly in @AviadoBio’s FTD clinical trial development process.
“Once you get a diagnosis like this, you very quickly become an expert in this field.”
#ATW23
AviadoBio retweeted
Day 2 of online #lifescience Innovation Workshops today at #GenesisLondon22
10:00-11:00 - Japanese Life Science Innovation 2022 with @LINKJ20160324
11:30-12:30 - Innovation Showcase with @AviadoBio, @ImaginAbInc, @eaglegen, @TheQuadram
Register here: ow.ly/zUIx50LUEar
AviadoBio retweeted
We are pleased to announce the finalists of our BioNewsRound Awards. Congratulations to:
@AviadoBio, @Domainex_UK, @eaglegen/@TheQuadram/@EarlhamInst, @ImaginAbInc, @MicrobioticaLtd, @NrgTherapeutics, @precisionlifeAI
Vote here: ow.ly/p3j750LOBJZ
#GenesisLondon22
AviadoBio retweeted
@AviadoBio is building a pipeline of investigational gene therapies for neurodegenerative diseases. Its lead preclinical candidate is AVB-101 for GRN frontotemporal dementia, an intra-thalamic gene supplementation therapy.
#entrepreneur #womeninbio
bioprocessonline.com/doc/fro…
AviadoBio retweeted
It was great to join @ChiOnwurah for a tour of @QMUL bio enterprise and see the important gene therapy research being carried out by @AviadoBio.
AviadoBio retweeted
.@AviadoBio has come out of stealth mode to announce the raising of an $80M Series A round to develop gene therapies to target neurodegenerative conditions such as #frontotemporaldementia (FTD) and #amyotrophiclateralsclerosis (ALS). Read more: ow.ly/CILg50H4wbU
AviadoBio retweeted
#Genetherapy #startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helm - More like this Pharm2Market.app | @JNJNews @FPrimeCapital @AviadoBio #dementia #als #genetherapy #executives #startups j.mp/3lCcLBD
AviadoBio retweeted
@AviadoBio completes an $80m Series A financing round to help progress their innovative #genetherapy platform, taking potential therapies for #neurodegenerative disease from lab to clinic. We're thrilled to be backing the team. #ALS #FTD
Learn more ➡️ bit.ly/3ogA5Xj
AviadoBio retweeted
In 2019, Christopher Shaw co-founded AviadoBio to pursue a new take on gene therapy for neurodegenerative disorders. On Thursday, he unwrapped an $80 million Series A round led to bring a lead candidate for frontotemporal dementia (FTD) into the clinic.
endpts.com/ex-novartis-busin…
AviadoBio retweeted
🎉 Congratulations, @AviadoBio--$80M series A raised for neurodegenerative #genetherapy platform.🧬 aviadobio.com/aviadobio-rais…
AviadoBio retweeted
After leading the commercialization of Novartis' Zolgensma, Lisa Deschamps has become CEO of U.K. start-up AviadoBio, which is advancing gene therapies for neurodegenerative diseases: An Emerging Company Profile by BioCentury's @BioBonanos buff.ly/3IcFlD1